SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K
CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 4, 2015

 

SYNTHETIC BIOLOGICS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-12584   13-3808303
(State or other jurisdiction of incorporation)   (Commission File No.)   (IRS Employer Identification No.)

 

 

9605 Medical Center Drive, Suite 270

Rockville, MD 20850

(Address of principal executive offices and zip code)

 

617 Detroit Street, Suite 100

Ann Arbor, MI 48104

(Mailing Address and zip code)

 

Registrant’s telephone number, including area code: (734) 332-7800

 

N/A 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

Synthetic Biologics, Inc. (the “Company”) entered into an amendment, dated as of December 4, 2015 (the “Amendment”), to its Employment Agreement with Jeffrey Riley, the Company’s President and Chief Executive Officer, dated March 18, 2015, to increase Mr. Riley’s annual base salary to $550,000.

 

The foregoing summary description of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of such document that is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

See Item 1.01 for a description of the Amendment. The information set forth in Item 1.01 is hereby incorporated by reference into this Item 5.02.

 

In addition, on December 4, 2015, the Company’s Board of Directors (the “Board”) approved the following option grants for the Company’s named executive officers: Mr. Riley was granted an option to purchase 500,000 shares of the Company’s common stock (the “Common Stock”); and Steven A. Shallcross, the Company’s Chief Financial Officer, was granted an option to purchase 100,000 shares of Common Stock. These options have an exercise price equal to the fair market value of the Common Stock on the date of grant (December 4, 2015), expire in seven years and vest monthly on a pro rata basis over 36 consecutive months. Mr. Riley and Mr. Shallcross also each received a cash bonus pursuant to the terms of their respective employment agreements.

 

The Board also approved the following compensation for members of the Board who are not employees of the Company: increased the annual cash fee by $7,500 to $42,000 and granted options to purchase 125,000 shares of Common Stock at an exercise price equal to the fair market value of the Common Stock on the date of grant (December 4, 2015), which options expire in seven years and vest annually on a pro rata basis over a three year period, with one-third of the options vesting on the grant date, one-third vesting on the one year anniversary of the grant date and the remaining one-third vesting on the two year anniversary of the grant date.

 

The options granted to the officers and directors were granted under the Company’s 2010 Stock Incentive Plan and the related stock option agreement. The form of stock option agreement is attached to this Current Report on Form 8-K as Exhibit 10.2 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

The following exhibits are being filed as part of this Current Report on Form 8-K.

 

Exhibit

Number

 

Description

   

10.1

Amendment to Employment Agreement by and between Synthetic Biologics, Inc. and Jeffrey Riley, dated as of December 4, 2015

   
10.2 Synthetic Biologics, Inc. Form of Option Agreement

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated:  December 10, 2015 SYNTHETIC BIOLOGICS, INC.
  (Registrant)
     
  By: /s/ Jeffrey Riley
    Name: Jeffrey Riley
    Title: President and Chief Executive Officer

 

 

 

 

 

EXHIBIT INDEX

  

Exhibit

Number

 

Description

   
10.1 Amendment to Employment Agreement by and between Synthetic Biologics, Inc. and Jeffrey Riley, dated as of December 4, 2015
   
10.2 Synthetic Biologics, Inc. Form of Option Agreement

 

 

 

 

 

 

 

Exhibit 10.1

 

 

AMENDMENT TO EMPLOYMENT AGREEMENT

This Amendment (this “ Amendment ”) dated as of the 4 th day of December, 2015 amends the Employment Agreement, dated March 18, 2015 (the “ Agreement ”) by and between Synthetic Biologics, Inc. (the “ Company ”) and Jeffrey Riley (“ Executive ”). Capitalized terms used herein without definition shall have the meanings assigned in the Agreement.  

 

WHEREAS , the Company desires to amend the Executive’s base salary as set forth in the Agreement.

 

NOW THEREFORE , for the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree to amend the Agreement as follows:

 

  1.

Amendment . Section 4 of the Agreement is deleted and replaced with the following:

 

“4. BASE SALARY . The Company agrees to pay the Executive a base salary (the “ Base Salary ”) at an annual rate of $550,000, payable semi-monthly in accordance with the regular payroll practices of the Company. The Executive’s Base Salary shall be subject to review and adjustment from time to time by the Board (or a committee thereof) in its sole discretion, but may not be decreased. The base salary as determined herein from time to time shall constitute “Base Salary” for purposes of this Agreement.”

 

2.    Severability . The provisions of this Amendment are severable and if any part or it is found to be unenforceable the other paragraphs shall remain fully valid and enforceable.

 

3.    No Other Amendments; Confirmation . All other terms of the Agreement shall remain in full force and effect. The Agreement, as amended by this Amendment, constitutes the entire agreement between the parties with respect to the subject matter thereof.

 

4.    Counterparts . This Amendment may be executed in one or more counterparts, each of which shall be deemed an original but both of which together shall constitute one and the same instrument.

 

5.    Choice of Law . This Amendment shall be construed and interpreted in accordance with the internal laws of the State of Delaware without regard to its conflict of laws principles.

 

[Signature page follows]

 

 

 

 

 

IN WITNESS WHEREOF , the parties hereto have executed this Amendment as of the day and year first written above.

 

  Company :
   
  SYNTHETIC BIOLOGICS, INC.
   
   
  By: /s/ Steven A. Shallcross
  Name: Steven A. Shallcross
  Title: Chief Financial Officer
     
  Executive:
  /s/ Jeffrey Riley
  JEFFREY RILEY

 

 

 

 

 

 

Exhibit 10.2

SYNTHETIC BIOLOGICS - WHITE BACKGROUND-CROPPED

FORM OF STOCK OPTION GRANT NOTICE

 

Synthetic Biologics, Inc.(the “ Company ”), pursuant to its 2010 Stock Incentive Plan (the “ Plan ”), hereby grants to Optionholder an option to purchase the number of shares of the Company’s Common Stock set forth below. This option is subject to all terms and conditions as set forth herein and in the related Option Agreement, the Plan and the Notice of Exercise, each of which are attached hereto and incorporated herein in their entirety.

 

Optionholder:

Date of Grant:

Vesting Commencement Date:

Number of Shares Subject to Option:

Exercise Price (Per Share):

Total Exercise Price:

Expiration Date:

 

Type of Grant: ¨ Incentive Stock Option 1 ¨ Non-statutory Stock Option
     
Vesting Schedule:    
     
Payment: By one or a combination of the following items (described in the Option Agreement):

 

· By cash or check

 

· By delivery of already owned shares

 

· By a “cashless exercise”

 

Additional Terms/Acknowledgements: The undersigned Optionholder acknowledges receipt of, and understands and agrees to, this Stock Option Grant Notice, the related Option Agreement and the Plan. Optionholder further acknowledges that as of the Date of Grant, this Stock Option Grant Notice, the Option Agreement and the Plan set forth the entire understanding between Optionholder and the Company regarding the acquisition of stock in the Company referred to herein and supersede all prior oral and written agreements on that subject.

 

SYNTHETIC BIOLOGICS, INC.   OPTIONHOLDER:  
           
By:        
Name:   Name:    
           
Date:     Date:    

 

ATTACHMENTS : Option Agreement, 2010 Stock Incentive Plan and Notice of Exercise

  


1 If this is an Incentive Stock Option, it (plus other outstanding Incentive Stock Options) cannot be first exercisable for more than $100,000 in value (measured by exercise price) in any calendar year. Any excess over $100,000 is a Non-statutory Stock Option.

 

 

 

 

FORM OF OPTION AGREEMENT

(INCENTIVE STOCK OPTION OR NON-STATUTORY STOCK OPTION)

 

Pursuant to your Stock Option Grant Notice (" Grant Notice ") and this Option Agreement, Synthetic Biologics, Inc. (the " Company ") has granted you an option under its 2010 Stock Incentive Plan (the " Plan ") to purchase the number of shares of the Company's Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan shall have the same definitions as in the Plan.

 

The details of your option are as follows:

 

1. VESTING .

 

Subject to the limitations contained herein, your option will vest as provided in your Grant Notice, provided that vesting will cease upon the termination of your employment or consulting arrangement, as applicable.

 

2. NUMBER OF SHARES AND EXERCISE PRICE .

 

The number of shares of common stock subject to your option and your exercise price per share referenced in your Grant Notice may be adjusted from time to time for certain events, including such as stock dividends, split ups, mergers, and the other events specified in the Plan.

 

3. METHOD OF PAYMENT .

 

Payment of the exercise price is due in full upon exercise of all or any part of your option. You may elect to make payment of the exercise price in cash or by check or by delivery to the Company of certificates representing shares of outstanding common stock of the Company already owned by you that are owned free and clear of any liens, claims, encumbrances or security interests together with stock powers duly executed and with signature guaranteed. In addition, you may make payment through a “cashless exercise” such that without the payment of any funds, the undersigned may exercise the Option and receive the net number of shares equal to (x) the number of shares as to which the Option is being exercised, multiplied by (y) a fraction, the numerator of which is the Fair Market Value per share (on such date as is determined by the Administrator) less the Exercise Price Per Share, and the denominator of which is such Fair Market Value Per Share (the number of net Shares to be received shall be rounded down to the nearest whole number of In the event payment is made by delivery of such shares, said shares shall be deemed to have a per share value equal to the per share market value of the shares on the date of exercise. Notwithstanding the foregoing, you may not exercise your option by tender to the Company of common stock to the extent such tender would violate the provisions of any law, regulation or agreement restricting the redemption of the Company's stock.

   

4. WHOLE SHARES .

 

You may exercise your option only for whole shares of common stock.

 

5. SECURITIES LAW COMPLIANCE .

 

Notwithstanding anything to the contrary contained herein, you may not exercise your option unless the shares of common stock issuable upon such exercise are then registered under the Securities Act or, if such shares of common stock are not then so registered, the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act. The exercise of your option also must comply with other applicable laws and regulations governing your option, and you may not exercise your option if the Company determines that such exercise would not be in material compliance with such laws and regulations.

 

 

 

 

6. TERM .

 

You may not exercise your option before the commencement or after the expiration of its term. The term of your option commences on the Date of Grant and unless otherwise specified in the Grant Notice expires upon the earliest of:

 

(a) Immediately upon the termination of your employment or consulting arrangement unless termination is effected by the Company without cause or by reason of your death or disability, in which case the provisions set forth in Section 10 Termination below shall apply (see Section 10. Termination);

 

(b) The Expiration Date indicated in your Grant Notice; or

 

(c) The day before the tenth (10 th ) anniversary of the Date of Grant.

 

If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the date of grant of your option and ending on the day three (3) months before the date of your option's exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability.

 

7. EXERCISE .

 

(a) You may exercise the vested portion of your option during its term by delivering a Notice of Exercise (in a form designated by the Company) together with the exercise price to the Vice President of Finance of the Company, or to such other person as the Company may designate, during regular business hours, together with such additional documents as the Company may then require. Each election to exercise this option shall be in writing, signed by you, and delivered or mailed to the Vice President of Finance of the Company at its principal office, 617 Detroit Street, Suite 100, Ann Arbor, MI 48104. In the event an option is exercised by the executor or administrator of your estate, or by the person or person to whom the option has been transferred by your will or the applicable laws of descent and distribution, the Company shall be under no obligation to deliver stock thereunder unless and until the Company is satisfied that the person or person exercising the option is or are your duly appointed executor or administrator or the person to whom the option has been transferred by your will or by the applicable laws of descent and distribution.

 

(b) By exercising your option you agree that, as a condition to any exercise of your option, the Company may require you to enter into an arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising by reason of (1) the exercise of your option, (2) the lapse of any substantial risk of forfeiture to which the shares of Common Stock are subject at the time of exercise, or (3) the disposition of shares of Common Stock acquired upon such exercise.

 

(c) If your option is an Incentive Stock Option, by exercising your option you agree that you will notify the Company in writing within fifteen (15) days after the date of any disposition of any of the shares of the Common Stock issued upon exercise of your option that occurs within two (2) years after the date of your option grant or within one (1) year after such shares of Common Stock are transferred upon exercise of your option.

 

 

 

 

8. PAYMENT .

 

(a) Payment in full by a certified or bank check should be made for all the shares of which your option is exercised at the time of such exercise, and no shares shall be delivered until such payment is made.

 

(b) Alternatively, payment may be made by delivering to the Company shares of outstanding Common Stock of the Company together with stock powers duly executed and with signature guaranteed. In the event payment is made in whole or in part by such shares, said shares shall be deemed to have a per share value equal to the closing price of the shares on the last trading day immediately preceding the date the shares are then being issued.

 

(c) The Company shall not be obligated to deliver any stock unless and until: (i) all applicable Federal and state laws and regulations have been complied with; and (ii) the shares to be delivered have been listed, or authorized to be added to the list by the applicable exchange where they are listed (currently NYSEAMEX); and all legal matters in connection with the issuance and delivery of the shares have been approved by counsel for the Company. You shall have no rights as a shareholder until the stock is actually delivered to you.

 

9. TRANSFERABILITY .

 

(a) If your option is an Incentive Stock Option, your option is not transferable, except by will or by the laws of descent and distribution, and is exercisable during your life only by you. Notwithstanding the foregoing, by delivering written notice to the Company, in a form satisfactory to the Company, you may designate a third party who, in the event of your death, shall thereafter be entitled to exercise your option.

 

(b) If your option is a Non-statutory Stock Option, your option is not transferable, except (i) by will or by the laws of descent and distribution, (ii) with the prior written approval of the Company, by instrument to an inter vivos or testamentary trust, in a form accepted by the Company, in which the option is to be passed to beneficiaries upon the death of the trustor (settlor) and (iii) with the prior written approval of the Company, by gift, in a form accepted by the Company, to a permitted transferee under Rule 701 of the Securities Act.

 

10. TERMINATION.

 

(a) If your employment terminates any reason not listed below, your option shall terminate immediately.

 

(b) If your employment is terminated by the Company without cause, your option shall terminate on the ninetieth (90 th ) day after such termination and you may exercise your option prior to such time but only to the extent to which you were entitled on the date of termination. Nothing herein shall be construed as extending the exercisability of your option to a date that is after the expiration date of the option set forth in this Option Agreement or a date that is more than ten (10) years after your option is granted.

 

(c) If your employment is terminated because of your disability, your option shall terminate one (1) year after such termination and you may exercise your option prior to such time but only to the extent to which you were entitled on the date of such termination. Nothing herein shall be construed as extending the exercisability of your option to a date that is after the expiration date of the option set forth in this Option Agreement or a date that is more than ten (10) years after the date your option is granted.

 

 

 

 

(d) If your employment is terminated as a result of your death, your option shall terminate one (1) year after the anniversary of your death, and your executor, administrator or other legal representative of your estate or the person or persons to whom your rights under your option shall pass by will or the laws of descent and distribution may exercise your option prior to such time but only to the extent to which you were entitled on the date of termination. Nothing herein shall be construed as extending the exercisability of your option to a date to a date that is after the expiration date of the option set forth in this Option Agreement or more than ten (10) years after the date your option is granted.

 

11. OPTION NOT A SERVICE CONTRACT .

 

Your option is not an employment or service contract, and nothing in your option shall be deemed to create in any way whatsoever any obligation on your part to continue in the employ of the Company or an affiliate, or of the Company or an affiliate to continue your employment. In addition, nothing in your option shall obligate the Company or an affiliate, their respective stockholders, Boards of Directors, officers or employees to continue any relationship that you might have as a Director or consultant for the Company or an affiliate.

 

12. WITHHOLDING OBLIGATIONS .

 

(a) At the time you exercise your option, in whole or in part, or at any time thereafter as requested by the Company, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or an affiliate, if any, which arise in connection with the exercise of your option.

 

(b) Upon your request and subject to approval by the Company, in its sole discretion, and compliance with any applicable legal conditions or restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon the exercise of your option a number of whole shares of Common Stock having a fair market value, determined by the Company as of the date of exercise based on the closing price of the shares on the last trading day immediately preceding the date the shares are then being issued , not in excess of the minimum amount of tax required to be withheld by law (or such lower amount as may be necessary to avoid classification of your option as a liability for financial accounting purposes). If the date of determination of any tax withholding obligation is deferred to a date later than the date of exercise of your option, share withholding pursuant to the preceding sentence shall not be permitted unless you make a proper and timely election under Section 83(b) of the Code, covering the aggregate number of shares of Common Stock acquired upon such exercise with respect to which such determination is otherwise deferred, to accelerate the determination of such tax withholding obligation to the date of exercise of your option. Notwithstanding the filing of such election, shares of Common Stock shall be withheld solely from fully vested shares of Common Stock determined as of the date of exercise of your option that are otherwise issuable to you upon such exercise. Any adverse consequences to you arising in connection with such share withholding procedure shall be your sole responsibility.

 

(c) You may not exercise your option unless the tax withholding obligations of the Company and/or any affiliate are satisfied. Accordingly, you may not be able to exercise your option when desired even though your option is vested, and the Company shall have no obligation to issue a certificate for such shares of Common Stock or release such shares of Common Stock from any escrow provided for herein unless such obligations are satisfied.

 

 

 

 

13. TAX CONSEQUENCES .

 

You hereby agree that the Company does not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes your tax liabilities. You shall not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from your option or your other compensation. In particular, you acknowledge that this option is exempt from Section 409A of the Code only if the exercise price per share specified in the Grant Notice is at least equal to the Fair Market Value per share of the Common Stock on the Date of Grant and there is no other impermissible deferral of compensation associated with the option.

 

14. NOTICES .

 

Any notices provided for in your option or the Plan shall be given in writing and shall be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company.

 

15. GOVERNING PLAN DOCUMENT .

 

Your option is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your option, and is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of your option and those of the Plan, the provisions of the Plan shall control.

 

16 . RIGHTS OF OPTIONEE.

 

This Option Agreement does not entitle you to any voting rights or, except for the foregoing notice provisions, any other rights as a shareholder of the Company. No dividends are payable or will accrue on your option or the Shares purchasable under this Option Agreement until, and except to the extent that, your option are exercised. Upon the surrender of your option and payment of the Exercise Price as provided above, the person or entity entitled to receive the shares of the Common Stock issuable upon such exercise shall be treated for all purposes as the record holder of such shares as of the close of business on the date of the surrender of your option for exercise as provided above. Upon the exercise of your option, you shall have all of the rights of a shareholder in the Company.

 

17 . GOVERNING LAW.

 

This Option Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Michigan without giving effect to its principles governing conflicts of law.

 

 

 

 

 

 

NOTICE OF EXERCISE

 

 

Date of Exercise:_____________

 

 

To Whom It May Concern:

 

This constitutes notice under my stock option that I elect to purchase the number of shares for the price set forth below.

 

  Type of option (check one): Incentive ¨ Non-statutory ¨  

 

  Stock option dated:      
         
  Number of shares as to which      
  option is exercised:      
         
  Certificates to be issued in name of:      
         
  Total exercise price: $    
         
  Cash payment delivered herewith: $    
         
  Value of ________________      
  shares of Synthetic Biologics, Inc. 2 : $    

 

Number of Shares To Be Received Based on Cashless Exercise _______________

 

By this exercise, I agree: (i) to provide such additional documents as you may require pursuant to the terms of the 2010 Stock Incentive Plan; (ii) to provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option; and (iii) if this exercise relates to an incentive stock option, to notify you in writing within fifteen (15) days after the date of any disposition of any of the shares of Common Stock issued upon exercise of this option that occurs within two (2) years after the date of grant of this option or within one (1) year after such shares of Common Stock are issued upon exercise of this option.

 

  Sincerely,  
     
     
  (Signature)  
     
     
  (Print Name)  

 


2 Shares must be valued in accordance with the terms of the option being exercised, and must be owned free and clear of any liens, claims, encumbrances or security interests. Certificates must be endorsed or accompanied by an executed assignment separate from certificate.